Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach
Monkeypox virus (mpox virus) outbreak has rapidly spread to 82 non-endemic countries. Although it primarily causes skin lesions, secondary complications and high mortality (1–10%) in vulnerable populations have made it an emerging threat. Since there is no specific vaccine/antiviral, it is desirable...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier Ltd
2023
|
Subjects: | |
Online Access: | View Fulltext in Publisher View in Scopus |